Interleukin-23 Antagonist class drugs
2 results
Ilumya (tildrakizumab-asmn)
(tildrakizumab-asmn)Sun Pharmaceutical Industries, Inc.
Usage: ILUMYA® is indicated for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Omvoh (mirikizumab-mrkz)
(mirikizumab-mrkz)Eli Lilly and Company
Usage: OMVOH is indicated for the treatment of moderately to severely active ulcerative colitis and moderately to severely active Crohn's disease in adults.